36 it-communication-"https:" "https:" "https:" Fellowship positions at Northeastern University
Sort by
Refine Your Search
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of
-
, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of
-
has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex
-
and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Scientific Communications - Medical Communications and Publications
-
, and scholarly activities. In partnership with Northeastern University, Dompé is offering a two-year fellowship in Global Medical Affairs - Medical Information & Operations and Medical Communications
-
information, medical communications and publications, field medical activities, promotional and medical review processes, and cross-functional collaboration. The fellow will help support the collection
-
degree from an ACPE-accredited institution • Eligible for pharmacist licensure in the State of Massachusetts • Excellent oral and written communication skills • Strong time management and leadership
-
, patient advocacy and care. No matter where your path starts at Chiesi, it leads to inspiring possibilities. Your future is our focus, and we are committed to nurturing your development in our dynamic
-
programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology